Buy Stocks Easy | About Us
June 24, 2021
Buy Stocks Easy | Online Stocks

ATXI


Buy Avenue Therapeutics, Inc. Stock (symbol: ATXI) Easy Online

Company Name: Avenue Therapeutics, Inc.

Symbol: ATXI

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2017

ATXI Current Share Price

Today's ATXI ( Avenue Therapeutics, Inc. ) opening price: $7.4400

Yesterday's ATXI ( Avenue Therapeutics, Inc. ) closing price: $7.4400

Avenue Therapeutics, Inc. Stock ( symbol: ATXI ) Price Chart since IPO (2017):

12 Months Avenue Therapeutics, Inc. Stock ( symbol: ATXI ) Price Chart

Popular Questions about Avenue Therapeutics, Inc. Public Stock ( ATXI )

A: Avenue Therapeutics, Inc. stock symbol (also called stock or share ticker) is ATXI

A: Avenue Therapeutics, Inc. IPO (Initial Public Offering) took place on 2017

A: Avenue Therapeutics, Inc.'s stock (ATXI symbol) price at ther IPO (initial Public Offering) was $7.4400

Q: Is ATXI stock worth buying at the moment?

A: If you were looking for a long-term investment portfolio and had bought the 'Avenue Therapeutics, Inc. stock (symbol: ATXI) at the beginning of 2019, at the opening share price of $6.0900, with a minimum of $200, by now your shares would be worth $6768 and your profit would be $6568 - SHOW ONLY IF PROFIT.

Buy Avenue Therapeutics, Inc. Stock Easy Online

Avenue Therapeutics, Inc. Stock Ticker Price Chart since IPO:





Avenue Therapeutics, Inc. Stock Price Yesterday



 


Avenue Therapeutics, Inc. Stock Price – Last Week




 


Avenue Therapeutics, Inc. Stock Price – Last Month




 


Avenue Therapeutics, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            https://seekingalpha.com/article/4312949-avenue-therapeutics-submits-nda-shares-still-cheap
                            

                                
Avenue Therapeutics Submits Its NDA; Shares Still Cheap

                                
                                
Avenue Therapeutics Submits Its NDA; Shares Still Cheap


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/11/1959218/0/en/Avenue-Therapeutics-Announces-Submission-of-New-Drug-Application-for-IV-Tramadol.html
                            

                                
Avenue Therapeutics Announces Submission of New Drug Application for IV Tramadol

                                
                                
NEW YORK, Dec.  11, 2019  (GLOBE NEWSWIRE) -- Avenue Therapeutics, ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/28/1936271/0/en/Avenue-Therapeutics-Announces-Publication-of-IV-Tramadol-Phase-1-Clinical-Data-in-Clinical-Pharmacology-in-Drug-Development.html
                            

                                
Avenue Therapeutics Announces Publication of IV Tramadol Phase 1 Clinical Data in Clinical Pharmacology in Drug Development

                                
                                
NEW YORK, Oct.  28, 2019  (GLOBE NEWSWIRE) -- Avenue Therapeutics, ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/18/1931841/0/en/Avenue-Therapeutics-to-Present-Phase-3-Bunionectomy-Study-of-IV-Tramadol-at-the-American-Society-of-Anesthesiologists-Annual-Meeting.html
                            

                                
Avenue Therapeutics to Present Phase 3 Bunionectomy Study of IV Tramadol at the American Society of Anesthesiologists Annual Meeting

                                
                                
NEW YORK, Oct.  18, 2019  (GLOBE NEWSWIRE) -- Avenue Therapeutics, ...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4270253-update-avenue-therapeutics-phase-3-reduces-risk-shares-bargain?source=feed_tag_long_ideas
                            

                                
Update On Avenue Therapeutics: Phase 3 Reduces Risk, Shares Are A Bargain

                                
                                
Shares of Avenue Therapeutics have done virtually nothing over the ...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4268082-avenue-therapeutics-inc-atxi-ceo-dr-lucy-lu-hosts-investor-update-call-transcript?source=feed_sector_transcripts
                            

                                
Avenue Therapeutics, Inc. (ATXI) CEO Dr.

                                
                                
Avenue Therapeutics, Inc. (ATXI) CEO Dr.


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4312949-avenue-therapeutics-submits-nda-shares-still-cheap
                            

                                
Avenue Therapeutics Submits Its NDA; Shares Still Cheap

                                
                                
Avenue Therapeutics Submits Its NDA; Shares Still Cheap


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/11/1959218/0/en/Avenue-Therapeutics-Announces-Submission-of-New-Drug-Application-for-IV-Tramadol.html
                            

                                
Avenue Therapeutics Announces Submission of New Drug Application for IV Tramadol

                                
                                
NEW YORK, Dec.  11, 2019  (GLOBE NEWSWIRE) -- Avenue Therapeutics, ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/28/1936271/0/en/Avenue-Therapeutics-Announces-Publication-of-IV-Tramadol-Phase-1-Clinical-Data-in-Clinical-Pharmacology-in-Drug-Development.html
                            

                                
Avenue Therapeutics Announces Publication of IV Tramadol Phase 1 Clinical Data in Clinical Pharmacology in Drug Development

                                
                                
NEW YORK, Oct.  28, 2019  (GLOBE NEWSWIRE) -- Avenue Therapeutics, ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/18/1931841/0/en/Avenue-Therapeutics-to-Present-Phase-3-Bunionectomy-Study-of-IV-Tramadol-at-the-American-Society-of-Anesthesiologists-Annual-Meeting.html
                            

                                
Avenue Therapeutics to Present Phase 3 Bunionectomy Study of IV Tramadol at the American Society of Anesthesiologists Annual Meeting

                                
                                
NEW YORK, Oct.  18, 2019  (GLOBE NEWSWIRE) -- Avenue Therapeutics, ...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4270253-update-avenue-therapeutics-phase-3-reduces-risk-shares-bargain?source=feed_tag_long_ideas
                            

                                
Update On Avenue Therapeutics: Phase 3 Reduces Risk, Shares Are A Bargain

                                
                                
Shares of Avenue Therapeutics have done virtually nothing over the ...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4268082-avenue-therapeutics-inc-atxi-ceo-dr-lucy-lu-hosts-investor-update-call-transcript?source=feed_sector_transcripts
                            

                                
Avenue Therapeutics, Inc. (ATXI) CEO Dr.

                                
                                
Avenue Therapeutics, Inc. (ATXI) CEO Dr.


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.